Safe from Harm: Making Pharmaceutical Manufacturing Fit for the Future

Ever-increasing customer expectations in the digital age, especially around speed of delivery, are putting further pressure on pharmaceutical companies to achieve fast time-to-market for new products. Across the industry, there has been a rapid increase in demand for approaches that deliver predictive and prescriptive maintenance for pharma.

In this European Pharmaceutical Manufacturer article, Kelly Doering, Senior Director Industry Marketing, Pharma at AspenTech explores how pharmaceutical manufacturing should embrace change in its solutions to stand out in the field and support digitalization in the pharmaceutical industry.

Safe from Harm: Making Pharmaceutical Manufacturing Fit for the Future

Why we collect this data

AspenTechは、当社の事業、可能な限り最善の製品やカスタマーサービスのご提供、そして全体的なユーザエクスペリエンスに関わるさまざまな理由でお客様の個人データを収集および処理する場合があります。当社はお客様の個人データを使用して適宜、アンケートや調査の管理、契約サービスの正確な提供、イベントへの登録、お客様の好みの理解、および不正または不正な活動の検出と防止を行う場合があります。個人データの収集と処理の詳細については、こちらからAspenTechのプライバシーおよびセキュリティポリシーを参照してください。

Safe from Harm: Making Pharmaceutical Manufacturing Fit for the Future

Hello . If this is not you

Thank you for downloading this resource

If your download did not begin click here